CHA News Article

CHA Submits Comments to BOP on Title 16 Revisions

CHA has submitted the attached comments and suggestions to the Board of Pharmacy on Title 16 proposed language. CHA has worked extensively with its members and community stakeholders to receive and process feedback on these critical sterile compounding regulations. In addition, the CHA Medication Safety Committee has designed four matrices on key elements of the proposed sterile compounding regulations, aimed at helping users better understand and compare key issues in the Title 16 rule revising present operations. The matrices cover physical environmental controls, temperature monitoring, lab testing requirements and frequency of documentation requirements.